Multi-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cells

Particle and Fibre Toxicology

Volumn 10, Issue 1, 2013, Pages

  Snyder Talkington, Brandi N ^a   Schwegler Berry, Diane ^a   Castranova, Vincent ^a   Qian, Yong ^a   Guo, Nancy L ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway epithelium; Co culture; Endothelium; MWCNT; Pulmonary fibrosis; Pulmonary inflammation

Indexed keywords

ACTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MULTI WALLED NANOTUBE; REACTIVE OXYGEN METABOLITE; STAT3 PROTEIN; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CAPILLARY; CAPILLARY ENDOTHELIUM; CAPILLARY PERMEABILITY; CELL INTERACTION; CELL SEPARATION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS; LUNG ALVEOLUS EPITHELIUM; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SMALL AIRWAY EPITHELIAL CELL; TOXICITY TESTING;

ACTINS; ANTIGENS, CD; BLOOD-AIR BARRIER; CADHERINS; CAPILLARIES; CAPILLARY PERMEABILITY; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; NANOTUBES, CARBON; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PNEUMOCYTES; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880912858     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-10-35     Document Type: Article

References (69)

1. Castranova V. Overview of current toxicological knowledge of engineered nanoparticles. J Occup Environ Med/ Am Coll Occup Environ Med 2011, 53:S14-S17.
2. Roco MC. Science and technology integration for increased human potential and societal outcomes. Ann N Y Acad Sci 2004, 1013:1-16. 10.1196/annals.1305.001, 15194603.
3. Scholars WWIC. Consumer Products: An Inventory of Nanotechnology-based Consumer Products Currenly on the Market http://www.nanotechproject.org 2012, Accessed 08/23/12.
4. Nel A, Xia T, Madler L, Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627. 10.1126/science.1114397, 16456071.
5. Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational health. J Nanopart Res 2005, 7:587-614.
6. Ajayan PM. Nanotubes from carbon. Chem Rev 1999, 99:1787-1800. 10.1021/cr970102g, 11849010.
7. Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354:56-58.
8. Yakobson BI, Smalley RE. Fullerene nanotubes: C 1,000,000 and Beyond: Some unusual new molecules - long, hollow fibers with tantalizing electronic and mechanical properties - have joined diamonds and graphite in the carbon family. Am Scientist 1997, 85:324-337.
9. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5. 10.1186/1743-8977-7-5, 2857820, 20307263.
10. Donaldson K, Poland CA. Inhaled nanoparticles and lung cancer - what we can learn from conventional particle toxicology. Swiss Med Wkly 2012, 142:w13547.
11. Pacurari M, Castranova V, Vallyathan V. Single- and multi-wall carbon nanotubes versus asbestos: are the carbon nanotubes a new health risk to humans?. J Toxicol Environ Health A 2010, 73:378-395. 10.1080/15287390903486527, 20155580.
12. Porter DW, Hubbs AF, Mercer RR, Wu N, Wolfarth MG, Sriram K, Leonard S, Battelli L, Schwegler-Berry D, Friend S, et al. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 2010, 269:136-147. 10.1016/j.tox.2009.10.017, 19857541.
13. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Friend S, Castranova V, Porter DW. Pulmonary fibrotic response to aspiration of multi-walled carbon nanotubes. Part Fibre Toxicol 2011, 8:21. 10.1186/1743-8977-8-21, 3152886, 21781304.
14. Porter DW, Hubbs AF, Chen BT, McKinney W, Mercer RR, Wolfarth MG, Battelli L, Wu N, Sriram K, Leonard S, et al. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 2012, Sep 13. [Epub ahead of print].
15. Muller J, Huaux F, Moreau N, Misson P, Heilier JF, Delos M, Arras M, Fonseca A, Nagy JB, Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol Appl Pharmacol 2005, 207:221-231. 10.1016/j.taap.2005.01.008, 16129115.
16. Snyder-Talkington BN, Qian Y, Castranova V, Guo NL. New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics. J Toxicol Environ Health B Crit Rev 2012, 15:468-492. 10.1080/10937404.2012.736856, 3513758, 23190270.
17. He X, Young SH, Schwegler-Berry D, Chisholm WP, Fernback JE, Ma Q. Multiwalled carbon nanotubes induce a fibrogenic response by stimulating reactive oxygen species production, activating NF-kappaB signaling, and promoting fibroblast-to-myofibroblast transformation. Chem Res Toxicol 2011, 24:2237-2248. 10.1021/tx200351d, 22081859.
18. Ye SF, Wu YH, Hou ZQ, Zhang QQ. ROS and NF-kappaB are involved in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes. Biochem Biophys Res Commun 2009, 379:643-648. 10.1016/j.bbrc.2008.12.137, 19121628.
19. Pacurari M, Qian Y, Fu W, Schwegler-Berry D, Ding M, Castranova V, Guo NL. Cell permeability, migration, and reactive oxygen species induced by multiwalled carbon nanotubes in human microvascular endothelial cells. J Toxicol Environ Health A 2012, 75:129-147.
20. Srivastava RK, Pant AB, Kashyap MP, Kumar V, Lohani M, Jonas L, Rahman Q. Multi-walled carbon nanotubes induce oxidative stress and apoptosis in human lung cancer cell line-A549. Nanotoxicology 2011, 5:195-207. 10.3109/17435390.2010.503944, 20804439.
21. Sargent LM, Reynolds SH, Castranova V. Potential pulmonary effects of engineered carbon nanotubes: in vitro genotoxic effects. Nanotoxicology 2010, 4:396-408. 10.3109/17435390.2010.500444, 20925447.
22. Warheit DB, Sayes CM, Reed KL. Nanoscale and fine zinc oxide particles: can in vitro assays accurately forecast lung hazards following inhalation exposures?. Environ Sci Technol 2009, 43:7939-7945. 10.1021/es901453p, 19921917.
23. Seagrave J, Mauderly JL, Seilkop SK. In vitro relative toxicity screening of combined particulate and semivolatile organic fractions of gasoline and diesel engine emissions. J Toxicol Environ Health A 2003, 66:1113-1132. 10.1080/15287390390213881, 12854533.
24. Sayes CM, Reed KL, Warheit DB. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol Sci 2007, 97:163-180. 10.1093/toxsci/kfm018, 17301066.
25. Stokstad E. Putting chemicals on a path to better risk assessment. Science 2009, 325:694-695. 10.1126/science.325_694, 19661414.
26. Hartung T. Toxicology for the twenty-first century. Nature 2009, 460:208-212. 10.1038/460208a, 19587762.
27. Collins FS, Gray GM, Bucher JR. Toxicology, Transforming environmental health protection. Science 2008, 319:906-907. 10.1126/science.1154619, 2679521, 18276874.
28. Brandenberger C, Rothen-Rutishauser B, Muhlfeld C, Schmid O, Ferron GA, Maier KL, Gehr P, Lenz AG. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. Toxicol Appl Pharmacol 2010, 242:56-65. 10.1016/j.taap.2009.09.014, 19796648.
29. Hermanns MI, Kasper J, Dubruel P, Pohl C, Uboldi C, Vermeersch V, Fuchs S, Unger RE, Kirkpatrick CJ. An impaired alveolar-capillary barrier in vitro: effect of proinflammatory cytokines and consequences on nanocarrier interaction. J R Soc, Interface / R Soc 2010, 7(Suppl 1):S41-S54.
30. Hermanns MI, Unger RE, Kehe K, Peters K, Kirkpatrick CJ. Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab Invest; J Tech Meth Pathol 2004, 84:736-752. 10.1038/labinvest.3700081, 23917879.
31. Kasper J, Hermanns MI, Bantz C, Maskos M, Stauber R, Pohl C, Unger RE, Kirkpatrick JC. Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures. Part Fibre Toxicol 2011, 8:6. 10.1186/1743-8977-8-6, 3040689, 21272353.
32. Klein SG, Hennen J, Serchi T, Blomeke B, Gutleb AC. Potential of coculture in vitro models to study inflammatory and sensitizing effects of particles on the lung. Toxicol In Vitro: Int J Published Assoc BIBRA 2011, 25:1516-1534.
33. Muller L, Riediker M, Wick P, Mohr M, Gehr P, Rothen-Rutishauser B. Oxidative stress and inflammation response after nanoparticle exposure: differences between human lung cell monocultures and an advanced three-dimensional model of the human epithelial airways. J R Soc, Interface / R Soc 2010, 7(Suppl 1):S27-S40.
34. Rothen-Rutishauser B, Blank F, Muhlfeld C, Gehr P. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin Drug Metab Toxicol 2008, 4:1075-1089. 10.1517/17425255.4.8.1075, 18680442.
35. Wottrich R, Diabate S, Krug HF. Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health 2004, 207:353-361. 10.1078/1438-4639-00300, 15471099.
36. Napierska D, Quarck R, Thomassen LC, Lison D, Martens JA, Delcroix M, Nemery B, Hoet PH. Amorphous silica nanoparticles promote monocyte adhesion to human endothelial cells: size-dependent effect. Small 2013, 9:430-438. 10.1002/smll.201201033, 23042701.
37. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001, 91:1487-1500.
38. Shi W, Xu J, Warburton D. Development, repair and fibrosis: what is common and why it matters. Respirology 2009, 14:656-665. 10.1111/j.1440-1843.2009.01565.x, 2747658, 19659647.
39. Strieter RM. What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 2008, 5:305-310. 10.1513/pats.200710-160DR, 2645241, 18403324.
40. Strieter RM, Mehrad B. New mechanisms of pulmonary fibrosis. Chest 2009, 136:1364-1370. 10.1378/chest.09-0510, 2773361, 19892675.
41. Snyder-Talkington BN, Pacurari M, Dong C, Leonard S, Schwegler-Berry D, Castranova V, Qian Y, Guo NL. Systematic analysis of multi-walled carbon nanotube-induced cellular signaling and gene expression in human small airway epithelial cells. Toxicol Sci 2013, 133:79-89. 10.1093/toxsci/kft019, 23377615.
42. Folkman J. Angiogenesis: an organizing principle for drug discovery?. Nature reviews Drug discovery 2007, 6:273-286. 10.1038/nrd2115, 17396134.
43. Hancock JT, Desikan R, Neill SJ. Role of reactive oxygen species in cell signalling pathways. Biochem Soc Trans 2001, 29:345-350. 10.1042/BST0290345, 11356180.
44. Roberts RA, Smith RA, Safe S, Szabo C, Tjalkens RB, Robertson FM. Toxicological and pathophysiological roles of reactive oxygen and nitrogen species. Toxicology 2010, 276:85-94. 10.1016/j.tox.2010.07.009, 20643181.
45. Tabima DM, Frizzell S, Gladwin MT. Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med 2012, 52:1970-1986. 10.1016/j.freeradbiomed.2012.02.041, 22401856.
46. Stapleton PA, Minarchick VC, Cumpston AM, McKinney W, Chen BT, Sager TM, Frazer DG, Mercer RR, Scabilloni J, Andrew ME, et al. Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study. Int J Mol Sci 2012, 13:13781-13803. 10.3390/ijms131113781, 3509550, 23203034.
47. Hirase T, Node K. Endothelial dysfunction as a cellular mechanism for vascular failure. Am J Physiol Heart Circ Physiol 2012, 302:H499-H505. 10.1152/ajpheart.00325.2011, 22081698.
48. Csortos C, Kolosova I, Verin AD. Regulation of vascular endothelial cell barrier function and cytoskeleton structure by protein phosphatases of the PPP family. Am J Physiol Lung Cell Mol Physiol 2007, 293:L843-L854. 10.1152/ajplung.00120.2007, 17693486.
49. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008, 1123:134-145. 10.1196/annals.1420.016, 18375586.
50. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992, 118:1511-1522. 10.1083/jcb.118.6.1511, 2289607, 1522121.
51. Harris ES, Nelson WJ. VE-cadherin: at the front, center, and sides of endothelial cell organization and function. Curr Opin Cell Biol 2010, 22:651-658. 10.1016/j.ceb.2010.07.006, 2948582, 20708398.
52. Tuder RM, Yun JH. Vascular endothelial growth factor of the lung: friend or foe. Curr Opin Pharmacol 2008, 8:255-260. 10.1016/j.coph.2008.03.003, 2622735, 18468486.
53. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005, 437:497-504. 10.1038/nature03987, 16177780.
54. Gavard J, Gutkind JS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 2006, 8:1223-1234. 10.1038/ncb1486, 17060906.
55. Muller WA. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 2011, 6:323-344. 10.1146/annurev-pathol-011110-130224, 3628537, 21073340.
56. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacological reports: PR 2009, 61:22-32.
57. Chang JF, Hsu SP, Pai MF, Yang JY, Chen HY, Wu HY, Peng YS. High soluble vascular cell adhesion molecule-1 concentrations predict long-term mortality in hemodialysis patients. Int Urol Nephrol 2013, Apr 6. [Epub ahead of print].
58. Gao H, Ward PA. STAT3 and suppressor of cytokine signaling 3: potential targets in lung inflammatory responses. Expert Opin Ther Targets 2007, 11:869-880. 10.1517/14728222.11.7.869, 17614756.
59. Rahman A, Fazal F. Blocking NF-kappaB: an inflammatory issue. Proc Am Thorac Soc 2011, 8:497-503. 10.1513/pats.201101-009MW, 3359076, 22052926.
60. Moodley YP, Misso NL, Scaffidi AK, Fogel-Petrovic M, McAnulty RJ, Laurent GJ, Thompson PJ, Knight DA. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol 2003, 29:490-498. 10.1165/rcmb.2002-0262OC, 12714376.
61. Hoefen RJ, Berk BC. The role of MAP kinases in endothelial activation. Vascul Pharmacol 2002, 38:271-273. 10.1016/S1537-1891(02)00251-3, 12487031.
62. Pietersma A, Tilly BC, Gaestel N, DeJong N, Lee JC, Koster JF, Sluiter W. P38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun 1997, 230:44-48. 10.1006/bbrc.1996.5886, 9020057.
63. Wang Q, Doerschuk CM. The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol 2001, 166:6877-6884.
64. Porter D, Sriram K, Wolfarth M, Jefferson A, Schwegler-Berry D, Andrew M, Castranova V. A biocompatible medium for nanoparticle dispersion. Nanotoxicology 2008, 2:144-154.
65. Mercer RR, Hubbs AF, Scabilloni JF, Wang L, Battelli LA, Schwegler-Berry D, Castranova V, Porter DW. Distribution and persistence of pleural penetrations by multi-walled carbon nanotubes. Part Fibre Toxicol 2010, 7:28. 10.1186/1743-8977-7-28, 2958975, 20920331.
66. Han JH, Lee EJ, Lee JH, So KP, Lee YH, Bae GN, Lee SB, Ji JH, Cho MH, Yu IJ. Monitoring multiwalled carbon nanotube exposure in carbon nanotube research facility. Inhal Toxicol 2008, 20:741-749. 10.1080/08958370801942238, 18569096.
67. Piao CQ, Liu L, Zhao YL, Balajee AS, Suzuki M, Hei TK. Immortalization of human small airway epithelial cells by ectopic expression of telomerase. Carcinogenesis 2005, 26:725-731. 10.1093/carcin/bgi016, 15677631.
68. Shao R, Guo X. Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis. Biochem Biophys Res Commun 2004, 321:788-794. 10.1016/j.bbrc.2004.07.033, 15358096.
69. Qian Y, Liu KJ, Chen Y, Flynn DC, Castranova V, Shi X. Cdc42 regulates arsenic-induced NADPH oxidase activation and cell migration through actin filament reorganization. J Biol Chem 2005, 280:3875-3884.